Nbt Bank N A Pfizer Inc Transaction History

Nbt Bank N A

$1.47 Billion
Q3 2024

A detailed history of Nbt Bank N A transactions in Pfizer Inc stock. As of the latest transaction made, Nbt Bank N A holds 219,944 shares of PFE stock, worth $5.88 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

219,944

Previous 230,381 4.53%

Holding current value

$5.88 Million

Previous $6.45 Million 1.26%

% of portfolio

0.43%

Previous 0.46%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $289,104 - $327,617	-10,437 Reduced 4.53%	219,944 $6.37 Million
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $538,517 - $631,042	21,319 Added 10.2%	230,381 $6.45 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $291,262 - $334,462	11,250 Added 5.69%	209,062 $5.8 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $272,300 - $353,688	10,421 Added 5.56%	197,812 $5.7 Million
Q3 2023 Oct 26, 2023	BUY	$32.09 - $37.51 $1.18 Million - $1.38 Million	36,829 Added 24.46%	187,391 $6.22 Million
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $185,223 - $214,299	-5,128 Reduced 3.29%	150,562 $5.52 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $164,571 - $214,247	-4,178 Reduced 2.61%	155,690 $6.35 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $125,542 - $163,881	-3,007 Reduced 1.85%	159,868 $8.19 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $72,991 - $89,104	-1,668 Reduced 1.01%	162,875 $7.13 Million
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $48,251 - $57,211	1,037 Added 0.63%	164,543 $8.63 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $177,830 - $220,354	-3,887 Reduced 2.32%	163,506 $8.47 Million
Q4 2021 Jan 27, 2022	SELL	$41.32 - $61.25 $148,710 - $220,438	-3,599 Reduced 2.1%	167,393 $9.89 Million
Q3 2021 Oct 18, 2021	SELL	$39.25 - $50.42 $146,324 - $187,965	-3,728 Reduced 2.13%	170,992 $7.35 Million
Q2 2021 Jul 28, 2021	BUY	$35.91 - $40.68 $9,516 - $10,780	265 Added 0.15%	174,720 $6.84 Million
Q1 2021 Apr 08, 2021	SELL	$33.49 - $37.77 $77,361 - $87,248	-2,310 Reduced 1.31%	174,455 $6.32 Million
Q4 2020 Jan 15, 2021	BUY	$33.47 - $42.56 $131,202 - $166,835	3,920 Added 2.27%	176,765 $6.51 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $40,989 - $48,089	1,291 Added 0.75%	172,845 $6.34 Million
Q2 2020 Jul 22, 2020	SELL	$30.12 - $36.54 $275,236 - $333,902	-9,138 Reduced 5.06%	171,554 $5.61 Million
Q1 2020 Apr 23, 2020	BUY	$27.03 - $38.62 $15,596 - $22,283	577 Added 0.32%	180,692 $5.9 Million
Q4 2019 Feb 05, 2020	SELL	$32.92 - $37.36 $25,183 - $28,580	-765 Reduced 0.42%	180,115 $7.06 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $144,483 - $187,352	-4,447 Reduced 2.4%	180,880 $6.5 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $47,112 - $52,896	-1,274 Reduced 0.68%	185,327 $8.03 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $115,687 - $127,102	-3,085 Reduced 1.63%	186,601 $7.92 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $40,316 - $45,965	-1,048 Reduced 0.55%	189,686 $8.28 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $336,530 - $408,191	-9,763 Reduced 4.87%	190,734 $8.41 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $2,143 - $2,285	-65 Reduced 0.03%	200,497 $7.27 Million
Q1 2018 May 22, 2018	SELL	$31.91 - $37.02 $25,336 - $29,393	-794 Reduced 0.39%	200,562 $7.12 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $503,190 - $533,902	-15,129 Reduced 6.99%	201,356 $7.29 Million
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $432,202 - $476,119	-13,942 Reduced 6.05%	216,485 $7.73 Million
Q2 2017 Aug 08, 2017	BUY	N/A	230,427	230,427 $7.74 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account